Literature DB >> 28802505

Soft Tissue Tumors of Uncertain Histogenesis: A Review for Dermatopathologists.

Darya Buehler1, Paul Weisman2.   

Abstract

The mesenchymal tumors discussed herein represent a heterogeneous group of neoplasms with distinctive morphologic, immunophenotypic, and molecular genetic features. These uncommon tumors often arise in the dermis and subcutis and can pose a major diagnostic challenge to dermatopathologists because they closely mimic melanoma, carcinoma, fibrous histiocytoma, schwannoma, or granulomatous inflammation. This article reviews the clinical presentation, histopathology, differential diagnosis, and diagnostic pitfalls of epithelioid sarcoma, clear cell sarcoma, perivascular epithelioid cell tumor, ossifying fibromyxoid tumor, pleomorphic hyalinizing angiectatic tumor, and hemosiderotic fibrolipomatous tumor. Associated molecular genetic findings are also briefly reviewed with an emphasis on their diagnostic usefulness.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clear cell sarcoma; Epithelioid sarcoma; Hemosiderotic fibrolipomatous tumor (HFLT); Ossifying fibromyxoid tumor (OFMT); PEComa; Pleomorphic hyalinizing angiectatic tumor (PHAT)

Mesh:

Year:  2017        PMID: 28802505     DOI: 10.1016/j.cll.2017.06.005

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  2 in total

Review 1.  Thoracoabdominal imaging of tuberous sclerosis.

Authors:  Cara E Morin; Nicholas P Morin; David N Franz; Darcy A Krueger; Andrew T Trout; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2018-08-04

2.  Malignant ossifying fibromyxoid tumor of the brain treated with post-operative fractionated stereotactic radiation therapy: A case report and literature review.

Authors:  Sasha Beyer; Nikhil T Sebastian; Rahul Neal Prasad; Jacqueline Chu; Kevin Liu; Kajal Madan; William Jiang; Jayeeta Ghose; Dukagjin M Blakaj; Joshua D Palmer; Mostafa Eltobgy; Jose Otero; James B Elder; Raju R Raval
Journal:  Surg Neurol Int       Date:  2021-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.